Search
for
Sort by
Research 121–150 of 252
- Roles of steroid receptors in the lung and COVID-19
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Letter to the Editor on “COVID-19 Infection in Men on Testosterone Replacement Therapy”
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Pathological sequelae of long-haul COVID
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- COVID-19 and Sex Differences
- Insights into disparities observed with COVID‐19
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Long-Term Effects of COVID-19
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Organoid technology for tissue engineering
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Male sex hormones, aging, and inflammation
- Coronavirus Infection and Cholesterol Metabolism